Illumina Countersues IBS, Qiagen for Infringement of Sequencing Patents
July 23, 2012
Illumina Countersues IBS, Qiagen for Infringement of Sequencing Patents
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Court Denies Illumina Appeal to Reconsider Ruling in Patent Suit Against Complete Genomics
March 27, 2013 / GenomeWeb Daily News - Mergers and Acquisitions — Both Successful and Failed — Dominated the NGS World in 2012
January 2, 2013 / In Sequence - Will Qiagen Acquisition of IBS Impact Patent Dispute with Illumina?
July 10, 2012 / In Sequence - Illumina Files Second Patent Infringement Suit Against Complete Genomics
June 18, 2012 / GenomeWeb Daily News - Enzo Files IP Infringement Suit Against Affy, Agilent, and Illumina
April 10, 2012 / GenomeWeb Daily News